Tourmaline Oil Corp. closed 3.0% short of its 52-week high of C$70.83, which the company reached on February 21st.

Tourmaline Oil Corp. closed 2.6% short of its 52-week high of C$70.83, which the company reached on February 21st.

The event will include presentations from Tourmaline's leadership team and Dr. Marc Bonaca, a cardiologist and vascular med Tourmaline Bio, Inc. ( (TRML) ) has released its Q3 earnings.

Tourmaline Capital Partners paid $76 million for the Columbus Center office complex in Coral Gables, which was facing ...

Morgan Stanley analyst Devin McDermott raised the firm’s price target on Tourmaline Oil (TRMLF) to C$80 from C$77 and keeps an Equal Weight ...

Tourmaline Oil Corp. (TSE:TOU – Get Free Report) has received an average rating of “Moderate Buy” from the nine ratings firms that are presently covering the firm, MarketBeat reports.

T he market expects Tourmaline Oil Corp. (TRMLF) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2024. This widely-known ...

Shares of Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report) have received a consensus recommendation of “Buy” from the ...

Ridker, and Tabassome Simon – – Cash, cash equivalents, and investments of $294.9 million as of December 31, 2024, providing expected cash runway into the second half of 2027 – NEW YORK, March 13, ...